Charles River Laboratories International (CRL) Net Margin (2009 - 2026)

Charles River Laboratories International has reported Net Margin for 18 years, with the latest figure at 0.08% in Q2 2026.

• On a quarterly basis, Net Margin fell 515.0% year-over-year to 0.08% in Q2 2026; TTM through Jun 2026 was 5.94%, a 423.0% decrease from a year earlier, with the FY2025 full-year figure at 3.59%, down 385.0% from the prior year.
• Net Margin was 0.08% for Q2 2026 at Charles River Laboratories International, up from 1.49% in the prior quarter.
• The five-year high for Net Margin was 18.46% in Q4 2023, with the low at 27.82% in Q4 2025.
• Average Net Margin over 5 years is 4.41%, with a median of 7.66% recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Net Margin soared 267 bps in 2022, then tumbled 3997 bps in 2024.
• Over 5 years, Net Margin stood at 17.19% in 2022, then gained by 7 bps to 18.46% in 2023, then plunged by 217 bps to 21.52% in 2024, then slipped by 29 bps to 27.82% in 2025, then soared by 100 bps to 0.08% in 2026.
• The last three Net Margin figures came in at 0.08% (Q2 2026), 1.49% (Q1 2026), and 27.82% (Q4 2025), per Business Quant data.